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Abstract
Background: Motilin, a peptide hormone has a direct excitatory effect on circular smooth muscle
strips derived from the human colon. Reduced plasma motilin concentration has been reported in
adults with chronic constipation. Erythromycin, a non-peptide motilin receptor agonist, induces
phase 3 of the migrating motor complex (MMC) in the antro-duodenum and also reduces oro-cecal
transit time. A pediatric study has reported an improvement in clinical symptoms of constipation
following erythromycin administration, but the effect on colon motility in children has not been
formally evaluated. We used colon manometry to study the effect of intravenous erythromycin
lactobionate at 1 mg/kg on colon motiltiy in ten children.
Methods: We selected patients with normal antroduodenal and colon manometry studies that
were performed simultaneously. All studies were performed for clinically indicated reasons. We
quantified the effect of erythromycin on colon contraction by calculating the area under the curve
(AUC).
Results: The mean (SE of mean) AUC in the colon during the fasting, post-erythromycin and
postprandial phases of the study was 2.1 mmHg/sec (0.35), 0.99 mmHg/sec (0.17) and 3.05 mmHg/
sec (0.70) respectively. The AUC following erythromycin was significantly less compared to the
fasting phase of the study (p < 0.01).
Conclusion: Erythromycin lacks colon prokinetic effect in children with chronic constipation
evaluated by colon manometry.
Background
Constipation accounts for 3% of general pediatric and
10–20% of pediatric gastroenterology outpatient visits
[1]. A majority of these patients have functional constipa-
tion and the symptoms improve following behavioral
modification and laxative treatment [2]. Almost 30% of
children with chronic constipation will have persistent
symptoms or relapses that can persist into adult life [3].
Children with chronic intractable constipation, who do
not respond to conventional medical therapy, require
manometric evaluation to exclude an underlying colon
neuromuscular abnormality.
Motilin is a 22-amino acid peptide hormone secreted by
the enterochromaffin cells of the small intestine [4,5]. It
exerts profound effect on gastric and small bowel motility
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by inducing the inter-digestive phase 3 of the migrating
motor complex (MMC) [6]. Peak plasma concentration of
motilin is associated with MMC, both in animals and
humans [7-9].
Conflicting results exists regarding the erythromycin effect
on circular smooth muscle strips derived from the human
colon. Few studies have reported the stimulatory effect of
erythromycin in human smooth muscle contractions
[10,11] and Nissan have reported lack of any excitatory
effect on human colon [12]. Studies have shown that
motilin receptor is expressed in the enteric neurons of the
colon [10,13] and plasma motilin concentration is
reduced in adults with chronic constipation [14]. Oral
and intravenous erythromycin has no effect on distal
colon contraction or transit in healthy human volunteers
[15].
Erythromycin is a non-peptide motilin receptor agonist
which induces phase 3 of the migrating motor complex in
the antro-duodenum. Several studies have reported that
erythromycin is safe and effective in improving feeding
intolerance in preterm infants and children [16-19]. The
prokinetic effect of erythromycin has also been reported
in older children with motility disorders [20]. The data
regarding the colon prokinetic effect of erythromycin is
controversial. Oral erythromycin has been shown to
reduce the colonic transit time assessed using radio
opaque markers in adults with chronic constipation [21].
However, another adult study using colon manometry
reported no significant improvement in colon motility
with erythromycin compared to a placebo [22]. To date,
no studies have evaluated the effect of erythromycin on
colon motility in children.
The aim of our study was to evaluate the effect of intrave-
nous erythromycin lactobionate (1 mg/kg) on colon
motility in children with chronic constipation and fecal
incontinence using colon manometry.
Methods
We retrospectively evaluated 10 simultaneously per-
formed antro-duodenal manometry (ADM) and colon
manometry (CM) studies performed at the Children's
Hospital of Wisconsin between June 2000 and June 2005.
These studies were performed to exclude an underlying
small bowel and/or colon motility disorder. Only patients
with normal antro-duodenal and colon motility studies
were included. The presenting symptoms were chronic
constipation in 8 patients, abdominal pain and fecal
incontinence in 1 and abdominal distension and pain in
1 patient. Hirschsprung's disease was excluded either by
anorectal manometry or rectal biopsies in all subjects.
This retrospective chart review study was approved by the
Children's Hospital of Wisconsin Human Research
Review Board (Protocol number: CHW 05/187, GC 31).
Informed consent was not obtained from the patients as
this was a retrospective chart review study.
All drugs known to affect the gastrointestinal motility
were discontinued at least 72 hours before the motility
studies. Patients fasted for at least 8 hours before the
study. All children were anesthetized without a muscle
relaxant. We waited for the child to recover completely
from the effects of the drug before starting the motility
tests [23]. Colonoscopy was performed to assist colon
manometry catheter placement. The tip of the colon
motility catheter was positioned in the cecum/ascending
colon in all subjects and the position was confirmed by
fluoroscopy. A water perfused manometry catheter with 8
recording sites was used for ADM and CM. Catheter posi-
tion was checked using fluoroscopy. The catheter was per-
fused with 0.45% sodium chloride solution at the rate of
0.4 ml per minute per recording site, using a pneumo-
hydraulic infusion system. The pressures were transmitted
to a transducer and recorded on a computer with special-
ized motility software (Medical Measurements System,
Amsterdam). We performed at least 2 hours fasting
recording of both ADM and CM studies, following which
we administered intravenous erythromycin lactobionate 1
mg/kg and performed another 60 minute of recording.
Next, the patients ate a meal appropriate for their age
(meal provided >30% of daily caloric requirement) and
the recording was continued for another 60 minutes [24].
Bisacodyl (5–10 mg) was administered through the cen-
tral lumen of the manometry catheter, directly into the
colon to induce high amplitude colon contractions
(HAPCs) and recording was continued for at least 30 min-
utes (Figure 1). This is a standard protocol for simultane-
ously performed ADM and CM studies performed at our
center.
Antro-duodenal manometry was considered normal if i)
phase 3 of the MMC, as defined by repetitive antral con-
tractions occurring at a rate of 2–3 per minute and 10–12
per minute small bowel contractions, lasted for more than
2 minutes with normal antegrade propagation ii) there
was normal stomach antrum and small bowel response to
a meal [25]. Colon manometry studies were considered
normal if there was a gastro-colonic response and sponta-
neous or bisacodyl stimulated antegrade propagating
HAPCs [26]. We defined HAPCs as colon contractions
with amplitude of at least 60 mmHg, and propagating
over at least 30 cm of colon.
All colon manometry studies were reviewed by an experi-
enced gastroenterologist and artifact was removed. The
area under the curve was calculated by measuring the area
under the pressure line for one 60 minutes period during
fasting, following erythromycin administration and afterBMC Gastroenterology 2008, 8:38 http://www.biomedcentral.com/1471-230X/8/38
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a meal. Increase in motility index following a meal is con-
sidered a gastro-colonic response. The CM recordings
were also evaluated for HAPCs.
We used SPSS software, version 10 for Windows (SPSS
Inc., Chicago, Illinois, USA). We compared the mean (SE
of mean) AUC using Student's t test. To compare the effect
of erythromycin and bisacodyl on colon contractions, we
used McNemar's test for disagreement.
Results
The mean age of the patients at the time of the study was
9.6 years (range 4–12 years); there were five females. In all
patients, we recorded phase 3 of the MMC following intra-
venous erythromycin and a normal postprandial antro-
duodenal manometry.
The mean (SE of mean) AUC in the colon during the fast-
ing, post erythromycin and postprandial phases of the
study was 2.1 mmHg/sec (0.35), 0.99 mmHg/sec (0.17)
and 3.05 mmHg/sec (0.70), respectively (Table 1). The
HAPCs in a patient with chronic constipation Figure 1
HAPCs in a patient with chronic constipation. High amplitude propagating contractions (HAPCs) following bisacodyl 
stimulation in a 10 year old boy with chronic constipation. The colon contractions are propagating from the cecum to the sig-
moid colon.
Cecum 
Ascending colon 
Proximal 
Transverse colon
Distal Transverse 
colon 
Descending colon
Proximal sigmoid 
colon 
Distal sigmoid 
colon 
Rectum
100 mmHg 
2 minutes
Table 1: AUC and HAPCs during fasting, following a meal and erythromycin
Fasting Period Postprandial period Post-erythromycin period Bisacodyl stimulation
Mean area under the curve in mm/sec (SE of mean) 2.1(0.35) 3.05 (0.70) 0.9 (0.17) NA
Mean number of HAPCs (range) 0.4 (0–1) 0.00 (0) 0.1 (0–1) 8.9 (1–16)
The mean area under the pressure line during fasting, following a meal and erythromycin lactobionate administration. The mean number of HAPCs 
recorded during each of these periods and following bisacodyl stimulation are also shownBMC Gastroenterology 2008, 8:38 http://www.biomedcentral.com/1471-230X/8/38
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AUC following erythromycin was significantly less com-
pared to the fasting phase of the study (p < 0.01), suggest-
ing that colon motor activity was reduced following
erythromycin administration.
All patients had a normal gastrocolonic response. Four
patients had spontaneous HAPCs during the fasting
period, one following erythromycin stimulation and
none following the meal. All patients had HAPCs with
bisacodyl stimulation, the mean number of HAPCs was
8.9 (range 1–16). McNemar's test for disagreement
between erythromycin and bisacodyl induced HAPC was
statistically significant (p = 0.004). The mean interval of
first HAPC after bisacodyl was 7.18 minutes (range 1–10
minutes).
Discussion
This retrospective study evaluates the effect of erythromy-
cin on colon motility in children with chronic constipa-
tion using colon manometry. All our patients had normal
antro-duodenal and colon manometric studies. The two
recognizable features of normal colon motility in children
are an increase in colon contractions following a meal
(gastrocolonic response) and HAPCs[26]. If spontaneous
HAPCs are not recorded during fasting and postprandial
period, bisacodyl is used to stimulate HAPCs [27]. All
patients in our study had a normal gastrocolonic response
and bisacodyl induced HAPCs. This suggests that none of
our patients had intestinal pseudo-obstruction or colon
neuromuscular abnormality. In our opinion, these
patients had functional constipation and/or fecal inconti-
nence.
All patients showed normal phase 3 MMC activity follow-
ing intravenous erythromycin lactobionate (1 mg/kg
dose). This shows that the dose of erythromycin lactobi-
onate used was adequate to stimulate the motilin recep-
tors in the foregut. In the colon there was a significant
decrease in the frequency and amplitude of contractions
following erythromycin lactobionate when compared to
the fasting period. This may be because the motilin recep-
tors in the colon have a higher threshold of activation
compared to small bowel. An adult study reported no
prokinetic effect of erythromycin on colon motility as
determined by colon manometry [22]. This suggests that
unlike the foregut, erythromycin lactobionate in a dose of
1 mg/kg does not have a prokinetic effect on the colon
and probably a higher concentration may be necessary to
stimulate the motilin receptors in the colon.
There is heterogeneity in the motilin receptor affinity for
erythromycin in the gastrointestinal tract [28]. It is possi-
ble that the colon motilin receptors may have reduced
affinity for erythromycin compared to the antral nerves or
the expression of motilin receptor may be reduced in the
colon. The limitation of our study is that we only evalu-
ated the effect of a single dose of erythromycin (1 mg/kg)
given intravenously. It is possible that a higher dose may
be necessary to induce a prokinetic effect on the colon. An
adult study using a higher oral dose of erythromycin (1 g/
day), reported improvement in segmental and colon tran-
sit time assessed using radio-opaque markers [21].
Conclusion
Our study suggests that erythromycin lactobionate at 1
mg/kg does not have a colon prokinetic effect in children
with chronic intractable constipation. Further studies are
needed, using a higher dose of erythromycin, to evaluate
the dose response curve and affinity of the colon motilin
receptors to erythromycin.
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